Drug Chatter -- Tracking biopharma stock chatter

Profile for Alimera Sciences, Inc. (ALIM)

« Back to company index

ALIM Chatter Timeline

Stock Ticker for ALIM

Most Active Tweeters for ALIM

UserTweets
@VisualStockRSRC 4
@Allstocknews 4
@ZolmaxNews 3
@AmericanBanking 3
@confcalltran 3

Recent Tweets for ALIM

ZolmaxNews @ZolmaxNews
$ALIM - Somewhat Positive Media Coverage Somewhat Unlikely to Affect Alimera Sciences #ALIM… https://t.co/TeZRX468YK
January 14th 2018, 10:01am
ZolmaxNews @ZolmaxNews
Somewhat Positive Media Coverage Somewhat Unlikely to Affect Alimera Sciences $ALIM Stock Price https://t.co/yrSzRspsS2
January 14th 2018, 10:01am
AmericanBanking @AmericanBanking
Reviewing Alimera Sciences $ALIM and Kadmon $KDMN https://t.co/nXwwFwM0Cq #stocks
January 14th 2018, 7:01am
WeekHerald @WeekHerald
Alimera Sciences $ALIM Raised to Hold at Zacks Investment Research https://t.co/zz6oA6mTXD
January 12th 2018, 5:01pm
Allstocknews @Allstocknews
$ALIM New Form S-8 POS for Alimera Sciences, Inc. From our Stock News Alerts App
January 12th 2018, 5:01pm
VisualStockRSRC @VisualStockRSRC
$ALIM - Post-effective Amendment to an S-8 Filing (s-8 Pos) https://t.co/KJw4e7pjUU
January 12th 2018, 4:01pm
confcalltran @confcalltran
Securities to be offered to employees in employee benefit plans, post-effective amendments https://t.co/iDGgIo85fC $ALIM
January 12th 2018, 4:01pm
noritsunagirota @noritsunagirota
Venbio Select Advisor Holds Stake in Alimera Sciences $ALIM https://t.co/CgDOO1MAcD
January 12th 2018, 9:01am
Allstocknews @Allstocknews
$ALIM New Form S-8 for Alimera Sciences, Inc. From our Stock News Alerts App
January 11th 2018, 4:01pm
VisualStockRSRC @VisualStockRSRC
$ALIM - Securities Registration: Employee Benefit Plan (s-8) https://t.co/jXJnSiY0oB
January 11th 2018, 4:01pm
confcalltran @confcalltran
Securities to be offered to employees in employee benefit plans https://t.co/Nm2gvfwgqf $ALIM
January 11th 2018, 4:01pm
ZolmaxNews @ZolmaxNews
Zacks Investment Research Upgrades Alimera Sciences $ALIM to Hold https://t.co/4tqRxvQVJD
January 11th 2018, 6:01am
StockSpotter @StockSpotter
$ALIM up 0.9% to 1.30 after our bullish setup alert Tue. Jan 9 after the close #swingtrading https://t.co/CzZoS6wMdj
January 10th 2018, 1:01pm
AmericanBanking @AmericanBanking
Strongbridge Biopharma $SBBP vs. Alimera Sciences $ALIM Critical Review https://t.co/7CnQckmxT8 #stocks
January 10th 2018, 8:01am
ConsumerFeed @ConsumerFeed
Alimera Sciences $ALIM Raised to “Hold” at Zacks Investment Research https://t.co/KjwZDc6VU7
January 10th 2018, 7:01am
dailypoliticaln @dailypoliticaln
Alimera Sciences $ALIM Upgraded to Hold at Zacks Investment Research https://t.co/90r5ifslUh
January 9th 2018, 11:01pm
AmericanBanking @AmericanBanking
Alimera Sciences $ALIM Upgraded to “Hold” by Zacks Investment Research https://t.co/91iltq42mj #stocks
January 8th 2018, 9:01pm
bbnsnews @bbnsnews
Alimera Sciences $ALIM Lifted to “Hold” at Zacks Investment Research https://t.co/8j6sW36NJA
January 8th 2018, 4:01pm
StockNewsNow @StockNewsNow
$ALIM Alimera Sciences Refinances Debt With New $40 Million Debt Facility From Solar Capital https://t.co/8dWSthVaFW
January 8th 2018, 10:01am
GafarovEmil @GafarovEmil
$ALIM entered into a $40 million Loan and Security Agreement with Solar Capital Ltd
January 8th 2018, 9:01am
StockTexts @StockTexts
$ALIM Alimera Sciences, Inc. SEC Filing: Form 8-K https://t.co/QnqgqRuPF6
January 8th 2018, 8:01am
confcalltran @confcalltran
Alimera Sciences Refinances Debt WITH NEW $40 MILLION DEBT FACILITY FROM SOLAR CAPITAL https://t.co/stTW1er2iI $ALIM
January 8th 2018, 8:01am
BehaviorFin @BehaviorFin
RT @stockboardinc: $ALIM Alimera Sciences Refinances Debt With New $40 Million Debt Facility From Solar Capital... - https://t.co/KMmnMHfnTO
January 8th 2018, 7:01am
stockboardinc @stockboardinc
$ALIM Alimera Sciences Refinances Debt With New $40 Million Debt Facility From Solar Capital... - https://t.co/KMmnMHfnTO
January 8th 2018, 7:01am
Allstocknews @Allstocknews
$ALIM Alimera Sciences Refinances Debt With New $40 Million Debt Facility From Solar Capital From our Stock News Alerts App
January 8th 2018, 7:01am
VisualStockRSRC @VisualStockRSRC
$ALIM - Alimera Sciences Refinances Debt With New $40 Million Debt Facility From Solar Capital https://t.co/nCnLmYM8j4
January 8th 2018, 7:01am
livetraderalrt @livetraderalrt
$ALIM 3.2m ago: Alimera Sciences Refinances Debt With New $40 Million Debt Facility From Solar Capital https://t.co/67Cyb7HmnS
January 8th 2018, 7:01am
GNWLive @GNWLive
Alimera Sciences Refinances Debt With New $40 Million Debt Facility From Solar Capital $ALIM https://t.co/LiJ6Cy7JI4
January 8th 2018, 7:01am
COCKRELLGROUP @COCKRELLGROUP
$ALIM Receives Acceptance of Filing to Obtain Approval for ILUVIEN® Non-Infectious Posterior Uveitis Indication in… https://t.co/y2JVBt5q9F
January 5th 2018, 8:01pm
MaisaCorp @MaisaCorp
$ALIM got validation of a Type II variation for Iluvien, which it submitted through the Mutual Recognition Procedu… https://t.co/WwrDgsbglS
January 4th 2018, 4:01pm
SEEKINGALPHA_FS @SEEKINGALPHA_FS
Alimera's European application for expanded use of Iluvien under review https://t.co/JqQwd3x1XM $ALIM
January 4th 2018, 12:01pm
MarketCurrents @MarketCurrents
Alimera's European application for expanded use of Iluvien under review https://t.co/Ur6XEe0s54 $ALIM
January 4th 2018, 12:01pm
StockNewsNow @StockNewsNow
$ALIM Alimera Sciences Receives Acceptance of Filing to Obtain Approval for ILUVIEN® Non-Infectious Posterior Uveit… https://t.co/Y1mIQ5HrGx
January 4th 2018, 11:01am
Briefingcom @Briefingcom
$ALIM: Alimera Sciences received validation of a Type II variation for ILUVIEN submitted on December 12, 2017 https://t.co/qdfYz4RVqh
January 4th 2018, 9:01am
newswithvalue @newswithvalue
$ALIM: Alimera Sciences (ALIM) Announces Acceptance of Filing to Obtain …: https://t.co/Hg1rzzN35H
January 4th 2018, 7:01am
VisualStockRSRC @VisualStockRSRC
$ALIM - Alimera Sciences Receives Acceptance of Filing to Obtain Approval for ILUVIEN® Non-Infectious https://t.co/5g5wRHmgzE
January 4th 2018, 7:01am
stockboardinc @stockboardinc
$ALIM Alimera Sciences Receives Acceptance of Filing to Obtain Approval for ILUVIEN® Non-Infectious Poste... - https://t.co/HxCF9YE1zg
January 4th 2018, 7:01am
Allstocknews @Allstocknews
$ALIM Alimera Sciences Receives Acceptance of Filing to Obtain Approval for ILUVIEN® Non-Infectious Posterior From our Stock News Alerts App
January 4th 2018, 7:01am
BioStocks @BioStocks
$ALIM Receives Acceptance of Filing to Obtain Approval for ILUVIEN Non-Infectious Posterior Uveitis Indication in Europe
January 4th 2018, 7:01am
GNWLive @GNWLive
Alimera Sciences Receives Acceptance of Filing to Obtain Approval for ILUVIEN® Non-Infectious Posterior $ALIM https://t.co/qDhGJB6SNa
January 4th 2018, 7:01am
ledgerzette @ledgerzette
Alimera Sciences $ALIM Receives News Impact Score of 0.10 https://t.co/srmqM6abEL
January 4th 2018, 3:01am
TheMarketsDaily @TheMarketsDaily
Contrasting Alimera Sciences $ALIM & Transition Therapeutics $TTHI https://t.co/H2b05lnnhX
January 3rd 2018, 1:01pm
RobertKnox73 @RobertKnox73
I really recommend everyone check this out for finding good stocks to trade https://t.co/TBr07e8h41 $ALIM $ALGN… https://t.co/8FUfVbLD4C
January 2nd 2018, 10:01pm
WatchlistN @WatchlistN
Transition Therapeutics $TTHI versus Alimera Sciences $ALIM Head-To-Head Analysis https://t.co/WVi9SCnaKG
January 1st 2018, 5:01am
windham_kathryn @windham_kathryn
Venbio Select Advisor Has Lifted By $350,000 Its Alimera Sciences $ALIM Holding https://t.co/XQVRILJ6g7
December 31st 2017, 3:12pm
intercooleronli @intercooleronli
Alimera Sciences $ALIM Raised to Sell at ValuEngine https://t.co/JvGoY8BzN0
December 31st 2017, 3:12pm
CFinancialNews @CFinancialNews
Alimera Sciences $ALIM Raised to Sell at ValuEngine https://t.co/QRGllY8tYF
December 31st 2017, 3:12pm
AmericanBanking @AmericanBanking
Alimera Sciences $ALIM Raised to Sell at ValuEngine https://t.co/Xv9Dl7PQEQ
December 31st 2017, 3:12pm
ConsumerFeed @ConsumerFeed
Alimera Sciences $ALIM Raised to Sell at ValuEngine https://t.co/G9GTB5ZUAW #acn
December 31st 2017, 3:12pm
dailypoliticaln @dailypoliticaln
Alimera Sciences $ALIM versus Transition Therapeutics $TTHI Head-To-Head Comparison https://t.co/DAySEZ9f3F
December 29th 2017, 2:12am

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.